|
US2019201360A1
|
|
Treatment of disease with n-acetyl kynurenine
|
|
CN109563150A
|
|
By the treatment for the disease that vascular hyperpermeability mediates
|
|
WO2016209969A1
|
|
Use of low molecular weight fractions of human serum albumin in treating diseases
|
|
AU2015305611A1
|
|
Treatment of joint conditions
|
|
AU2015203544A1
|
|
Methods and products for treatment of diseases
|
|
AU2015203100A1
|
|
Method for treatment of diseases
|
|
AU2015201106A1
|
|
Methylphenidate derivatives and uses of them
|
|
US2014286913A1
|
|
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
EA030414B1
|
|
Methods for producing diketopiperazines and compounds containing diketopiperazines
|
|
SG10201705044YA
|
|
Method for treatment of diseases
|
|
AU2013270553A1
|
|
Treatment of t-cell mediated diseases
|
|
AU2012258393A1
|
|
Methylphenidate derivatives and uses of them
|
|
US2014294738A1
|
|
Treatment of rhinitis
|
|
AU2012323320A1
|
|
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
|
CN104958752A
|
|
Treatment of degenerative joint disease
|
|
EP2763678A1
|
|
Treatment of rhinitis
|
|
SG10201507120TA
|
|
Treatment of diseases
|
|
NZ624015A
|
|
Methods and products for treatment of diseases
|
|
EP2517722A2
|
|
Synthesis of diketopiperazines
|
